Collegium Pharmaceutical, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 35.2% | 35.2% | 10.3% |
| FY2022 | -12.8% | -12.8% | -2.1% |
| FY2023 | 24.6% | 24.6% | 4.2% |
| FY2024 | 30.2% | 30.2% | 4.2% |
| FY2025 | 20.8% | 20.8% | 3.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 35.2% | 35.2% | 10.3% |
| FY2022 | -12.8% | -12.8% | -2.1% |
| FY2023 | 24.6% | 24.6% | 4.2% |
| FY2024 | 30.2% | 30.2% | 4.2% |
| FY2025 | 20.8% | 20.8% | 3.8% |